Eli Lilly, the manufacturer of the GLP-1 / GIP agonist tirzepatide (Mounjaro, Zepbound) has announced the development of bimagrumab (LY3985863), an injected monoclonal antibody that binds the activin/myostatin type II receptors ActRIIA and ActRIIB and blocks ligand binding
(2022) Prenatal and postnatal choline supplementation in fetal alcohol spectrum disorder, Nutrients, Vol
Healthcare providers must be vigilant in monitoring patients for signs of serotonin toxicity, especially those taking serotonergic drugs
It also supports better blood sugar control in individuals with type 2 diabetes
At least 72 hours have passed since your last Monday injection
Once a consistent time is set, steady timing helps maintain the flat profile and simplifies interpretation of fasting readings